Hemp analysis at Reference Analytics

In an increasing number of countries, the use of cannabis for medical purposes is being legalized. Europe is expected to become the largest legal cannabis market in the world – with a sales volume of several billion EUR by 2028.

 Cannabis has been classified as a medical product by EU authorities, making EudraLex Volume 4 of the „Rules for Medical Devices in the European Union“ – EU GMP for short – applicable.

Hanf Analytik

GMP Certification for Cannabinoid Analytic

GMP certification ensures that drugs are produced in „pharmaceutical quality,“ because end users expect the hemp products they buy to be


do not contain impurities

do not pose any health risks.

Companies that have their products

  • tested by third-party laboratories
  • publish their certificates of analysis
  • produce in compliance with GMP

ensure a significant competitive advantage for themselves.

Reference Analytics offers a broad analytical spectrum to support their clients in this task!

What we offer in hemp analysis

Potency test: Determination of THC content

Profiling: Determination and quantification of the most known cannabinoids such as CBD, CBDA, T-THC, D9THC, THCA, D8THC, T-CBG, CBG, CBGA, CBN, CBC, THCV, CBDV und CBDVA

Mycotoxin determination: determination of aflatoxin

Determination of impurities due to residual solvents, pesticides, heavy metals


Cannabinoid Analtyics Methods

We use our entire methodological portfolio to meet individual requirements in cannabis analysis.    

  • GC-MS 
  • HPLC 
  • LC-MS/MS 

Learn more on residual solvents in cannabis products. 

Contact us today!

Reference Analytics is happy to support pharmaceutical companies in the analysis of their hemp products. We will be happy to prepare a suitable offer for you: office@reference-analytics.com